158 related articles for article (PubMed ID: 35675780)
1. Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides.
Bonté PE; Arribas YA; Merlotti A; Carrascal M; Zhang JV; Zueva E; Binder ZA; Alanio C; Goudot C; Amigorena S
Cell Rep; 2022 Jun; 39(10):110916. PubMed ID: 35675780
[TBL] [Abstract][Full Text] [Related]
2. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes.
Chong C; Müller M; Pak H; Harnett D; Huber F; Grun D; Leleu M; Auger A; Arnaud M; Stevenson BJ; Michaux J; Bilic I; Hirsekorn A; Calviello L; Simó-Riudalbas L; Planet E; Lubiński J; Bryśkiewicz M; Wiznerowicz M; Xenarios I; Zhang L; Trono D; Harari A; Ohler U; Coukos G; Bassani-Sternberg M
Nat Commun; 2020 Mar; 11(1):1293. PubMed ID: 32157095
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.
Qi YA; Maity TK; Cultraro CM; Misra V; Zhang X; Ade C; Gao S; Milewski D; Nguyen KD; Ebrahimabadi MH; Hanada KI; Khan J; Sahinalp C; Yang JC; Guha U
Mol Cell Proteomics; 2021; 20():100136. PubMed ID: 34391887
[TBL] [Abstract][Full Text] [Related]
4. Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery.
Zhang B; Bassani-Sternberg M
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899131
[TBL] [Abstract][Full Text] [Related]
5. An integrative proteogenomics approach reveals peptides encoded by annotated lincRNA in the mouse kidney inner medulla.
Flower CT; Chen L; Jung HJ; Raghuram V; Knepper MA; Yang CR
Physiol Genomics; 2020 Oct; 52(10):485-491. PubMed ID: 32866085
[TBL] [Abstract][Full Text] [Related]
6. Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue.
Hirama T; Tokita S; Nakatsugawa M; Murata K; Nannya Y; Matsuo K; Inoko H; Hirohashi Y; Hashimoto S; Ogawa S; Takemasa I; Sato N; Hata F; Kanaseki T; Torigoe T
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34185709
[TBL] [Abstract][Full Text] [Related]
7. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
Shraibman B; Barnea E; Kadosh DM; Haimovich Y; Slobodin G; Rosner I; López-Larrea C; Hilf N; Kuttruff S; Song C; Britten C; Castle J; Kreiter S; Frenzel K; Tatagiba M; Tabatabai G; Dietrich PY; Dutoit V; Wick W; Platten M; Winkler F; von Deimling A; Kroep J; Sahuquillo J; Martinez-Ricarte F; Rodon J; Lassen U; Ottensmeier C; van der Burg SH; Thor Straten P; Poulsen HS; Ponsati B; Okada H; Rammensee HG; Sahin U; Singh H; Admon A
Mol Cell Proteomics; 2019 Jun; 18(6):1255-1268. PubMed ID: 31154438
[TBL] [Abstract][Full Text] [Related]
8. pXg: Comprehensive Identification of Noncanonical MHC-I-Associated Peptides From De Novo Peptide Sequencing Using RNA-Seq Reads.
Choi S; Paek E
Mol Cell Proteomics; 2024 Apr; 23(4):100743. PubMed ID: 38403075
[TBL] [Abstract][Full Text] [Related]
9. BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens.
Cuevas MVR; Hardy MP; Larouche JD; Apavaloaei A; Kina E; Vincent K; Gendron P; Laverdure JP; Durette C; Thibault P; Lemieux S; Perreault C; Ehx G
Genome Biol; 2023 Aug; 24(1):188. PubMed ID: 37582761
[TBL] [Abstract][Full Text] [Related]
10. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
Shraibman B; Barnea E; Kadosh DM; Haimovich Y; Slobodin G; Rosner I; López-Larrea C; Hilf N; Kuttruff S; Song C; Britten C; Castle J; Kreiter S; Frenzel K; Tatagiba M; Tabatabai G; Dietrich PY; Dutoit V; Wick W; Platten M; Winkler F; von Deimling A; Kroep J; Sahuquillo J; Martinez-Ricarte F; Rodon J; Lassen U; Ottensmeier C; van der Burg SH; Thor Straten P; Poulsen HS; Ponsati B; Okada H; Rammensee HG; Sahin U; Singh H; Admon A
Mol Cell Proteomics; 2018 Nov; 17(11):2132-2145. PubMed ID: 30072578
[TBL] [Abstract][Full Text] [Related]
11. Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Tretter C; de Andrade Krätzig N; Pecoraro M; Lange S; Seifert P; von Frankenberg C; Untch J; Zuleger G; Wilhelm M; Zolg DP; Dreyer FS; Bräunlein E; Engleitner T; Uhrig S; Boxberg M; Steiger K; Slotta-Huspenina J; Ochsenreither S; von Bubnoff N; Bauer S; Boerries M; Jost PJ; Schenck K; Dresing I; Bassermann F; Friess H; Reim D; Grützmann K; Pfütze K; Klink B; Schröck E; Haller B; Kuster B; Mann M; Weichert W; Fröhling S; Rad R; Hiltensperger M; Krackhardt AM
Nat Commun; 2023 Aug; 14(1):4632. PubMed ID: 37532709
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.
Lai W; Li D; Kuang J; Deng L; Lu Q
Brain Behav; 2022 May; 12(5):e2575. PubMed ID: 35429411
[TBL] [Abstract][Full Text] [Related]
13. Proteogenomics of glioblastoma associates molecular patterns with survival.
Yanovich-Arad G; Ofek P; Yeini E; Mardamshina M; Danilevsky A; Shomron N; Grossman R; Satchi-Fainaro R; Geiger T
Cell Rep; 2021 Mar; 34(9):108787. PubMed ID: 33657365
[TBL] [Abstract][Full Text] [Related]
14. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel Splice Variant of Neural Cell Adhesion Molecule in Glioblastoma Through Proteogenomics Analysis.
Jayaram S; Balakrishnan L; Singh M; Zabihi A; Ganesh RA; Mangalaparthi KK; Sonpatki P; Gupta MK; Amaresha CB; Prasad K; Mariswamappa K; Pillai S; Lakshmikantha A; Shah N; Sirdeshmukh R
OMICS; 2018 Jun; 22(6):437-448. PubMed ID: 29927716
[TBL] [Abstract][Full Text] [Related]
16. RepExpress: A Novel Pipeline for the Quantification and Characterization of Transposable Element Expression from RNA-seq Data.
Stockwell PA; Lynch-Sutherland CF; Chatterjee A; Macaulay EC; Eccles MR
Curr Protoc; 2021 Aug; 1(8):e206. PubMed ID: 34387946
[TBL] [Abstract][Full Text] [Related]
17. Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression Profiles.
Bonnett SA; Rosenbloom AB; Ong GT; Conner M; Rininger ABE; Newhouse D; New F; Phan CQ; Ilcisin S; Sato H; Lyssand JS; Geiss G; Beechem JM
Cancer Res Commun; 2023 May; 3(5):763-779. PubMed ID: 37377888
[TBL] [Abstract][Full Text] [Related]
18. PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.
Tan X; Xu L; Jian X; Ouyang J; Hu B; Yang X; Wang T; Xie L
Cells; 2023 Mar; 12(5):. PubMed ID: 36899918
[TBL] [Abstract][Full Text] [Related]
19. Human Endogenous Retroviruses in Glioblastoma Multiforme.
Yuan Z; Yang Y; Zhang N; Soto C; Jiang X; An Z; Zheng WJ
Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33917421
[TBL] [Abstract][Full Text] [Related]
20. Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.
Merlotti A; Sadacca B; Arribas YA; Ngoma M; Burbage M; Goudot C; Houy A; Rocañín-Arjó A; Lalanne A; Seguin-Givelet A; Lefevre M; Heurtebise-Chrétien S; Baudon B; Oliveira G; Loew D; Carrascal M; Wu CJ; Lantz O; Stern MH; Girard N; Waterfall JJ; Amigorena S
Sci Immunol; 2023 Feb; 8(80):eabm6359. PubMed ID: 36735774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]